Neurotech Solutions

Sector: Medical Device Innovations

Subsector: Neurology

Geography: Israel

Regulatory status: Class 3 clinical trials


Neurotech Solutions is a leader in the area of Attention with an expertise in Attentional Profiling and Analytics.  The company enjoys significant success with its MOXO tool for ADHD diagnosis already clinically adopted by numerous clinicians across the globe. Neurotech is highly engaged in innovative developments in these areas and strive to provide advanced solutions to help improve people’s everyday functioning, well-being, academic abilities and achievements.